Carl Zeiss Meditec AG
CZMWY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | -1.20 | 0.15 | -0.87 |
| FCF Yield | 5.65% | 0.00% | 0.00% | -0.66% |
| EV / EBITDA | 17.76 | 87.38 | 53.52 | 106.95 |
| Quality | ||||
| ROIC | 3.49% | 0.00% | 1.73% | 0.00% |
| Gross Margin | 114.02% | 52.71% | 53.88% | 51.40% |
| Cash Conversion Ratio | 2.52 | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 2.16% | 1.58% | 2.38% | 1.98% |
| Free Cash Flow Growth | 0.00% | 0.00% | 100.00% | -169.73% |
| Safety | ||||
| Net Debt / EBITDA | 0.47 | 0.00 | 1.19 | 0.00 |
| Interest Coverage | 11.32 | 8.25 | 10.16 | 4.06 |
| Efficiency | ||||
| Inventory Turnover | 0.60 | 0.00 | 0.47 | 0.00 |
| Cash Conversion Cycle | 228.85 | 0.00 | 221.37 | 0.00 |